期刊文献+

浅谈甲状腺未分化癌的病理诊断 被引量:10

Pathological diagnosis of undifferentiated thyroid carcinoma
下载PDF
导出
摘要 甲状腺未分化癌是恶性程度最高的肿瘤之一,发病率低,但死亡率却极高,多见于老年女性,表现为迅速增大的颈部肿块,有明显周围组织受累症状,易发生早期转移。甲状腺未分化癌的组织学特点取决于梭形细胞、鳞状或上皮样细胞、巨细胞三种成分的构成,细胞多形性明显,核分裂像多见,表现为肉瘤样、表皮样甚至鳞样形态改变,或其他罕见形态变异型。肿瘤细胞通常表达角蛋白和PAX-8,而甲状腺球蛋白(Tg)及转录因子(TTF-1)阴性。分子遗传学改变主要包括信号转导通路上关键节点的突变、染色体异常以及表观遗传学改变。未分化癌的组织学起源尚未完全明确,普遍认为可能是分化好的甲状腺癌去分化的终末阶段。 Undifferentiated thyroid carcinoma(UTC) is one of the most aggressive malignant tumors with lower morbidity and higher mortality. UTC usually occurs in elderly female patients. Most cases present with a rapidly enlarging neck mass with local compressive symptoms and early metastases. The morphological features depend on admixture of three main histological patterns(spindle, giant and epithelioid cells)with marked pleomorphism and numerous mitoses. It shows sarcomatoid, epithelioid-squamoid or other rare variants changes. Tumor cells are usually immunoreactive for cytokeratin and PAX-8, but negative for thyroglobulin and TTF-1. The genetic changes include mutations of the key-points in signal pathway, aberrations of chromosomal regions, and modifications of epigenetic targets. It is widely accepted that UTC represents a terminal dedifferentiated of well differentiated thyroid carcinoma, although the definite histogenesis is not clear.
作者 唐峰 杜尊国
出处 《上海医药》 CAS 2016年第6期7-10,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 甲状腺癌 未分化 组织学 thyroid carcinoma undifferentiated histology
  • 相关文献

参考文献9

  • 1The International Agency for Reserch on Cancer, DeLellis R, Lloyd R, et al. Pathology and genetics of tumors of endocrine organs(IARC WHO Classification of Tumors)[M]. Lyon: World Health Organization, 2004: 77-80.
  • 2Lebastchi AH, Callender GG. Thyroid cancer[J]. Curt Probl Cancer, 2014, 38(2): 48-74.
  • 3Ragazzi M, Ciarrocchi A, Sancisi V, et al. Update on anaplastic thyroid carcinoma: morphological, moleculal; and genetic features of the most aggressive thyroid cancer[J/OL]. Int J Endocrinol, 2014: 790834. doi: 10.1155/2014/790834.
  • 4Papi G, Corrado S, LiVolsi VA. Primary spindle cell lesions of the thyroid gland, an overview[J]. Am J Clin Pathol, 2006,125 (Suppl): $95-S123.
  • 5Canos JC, Serrano A, Matias-Guiu X. Paucicellular variant of anaplastic thyroid carcinoma: report of two cases[J]. Endocr Palhol, 2001, 12(2): 157-161.
  • 6Lai ME, Faa G, Serra S, et al. Rhabdoid tumor of the thyroid gland: a variant of anaplastic carcinoma[J]. Arch Pathol Lab Med, 2005, 129(3): e55-e57.
  • 7Dominguez-Malagon H, Flores-Flores G, Vilchis JJ. Lymphoepithelioma-like anaplastic thyroid carcinoma: report of a case not related to Epstein-Barr virus[J]. Ann Diagn Pathol, 2001.5(1): 21-24.
  • 8Vu-Phan D, Koenig RJ. Genetics and epigenetics of sporadic thyroid cancer[J]. Mol Cell Endocrinol, 2014, 386(1-2): 55- 66.
  • 9Aldinger KA, Samaan NA, Ibanez M, et al. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid[J]. Cancer, 1978, 41(6): 2267-2275.

同被引文献46

  • 1罗华,蒋堃.病理检查对甲状腺未分化癌的诊断效果观察[J].当代医药论丛,2014,12(10):59-60. 被引量:1
  • 2田丰秋,吕丽,冯晓海,王乃玉,张文波,王莉芬.CK19,P53,P63,EMA,P170蛋白在甲状腺乳头状癌中的表达及病理意义[J].大连医科大学学报,2007,29(2):103-105. 被引量:4
  • 3The International Agency for Reserch on Cancer. Pathology and genet.ics of tumors of endocrineorgans(IARC WHO Classification of Tumors)[M]. Lyon:World Health Organization, 2004: 77-80.
  • 4Lebastchi AH, Callender GG. Thyroid cancer[J]. Curr ProblCancer,2014,38(2): 48-74.
  • 5Buton L, Morel O, Gault P, whole-body scan findings thyroid carcinoma: report et al. False-positive iodine- 131 in patients with differentiated ofl 1 cases and review of theliterature[J]. Ann Endocrinol (Paris), 2013, 74(3): 221-230.
  • 6Kim SS, Lee BJ, Lee JC, et al. Preoperative serum hyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extra thyroidal extension in Korean patients: a single-center experience[J]. Endocrine, 2011, 39(3): 259-265.
  • 7Lee JW, Lee SM, Lee DH, et al. Clinical Utility of 18F-FDG PET/CT concurrent with ~I therapy in intermediate-to-high- risk patients with differentiated thyroid cancer: dual-center experience with 286 patients[J]. J Nucl Med, 2013, 54(8): 1230-1236.
  • 8Agate L, Lorusso L, Elisei R. New and old knowledge on differentiated thyroid cancer ~idemiolo~ and risk factors[J]. J End~rin0i ~Vest, 2012, 35(6 Suppl): 3~9.
  • 9冯影,高明.94例甲状腺未分化癌临床分析[J].天津医科大学学报,2008,14(2):207-209. 被引量:14
  • 10林毅,吴艺捷.甲状腺细针穿刺细胞学检查对甲状腺结节的诊断价值[J].实用预防医学,2009,16(5):1549-1550. 被引量:12

引证文献10

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部